November 07, 2012 at 10:03 AM EST
ORIX Ventures Announces $10 Million Growth Capital Commitment to Talyst

ORIX Ventures announces the closing of a $10 million growth capital commitment to Talyst. The funding is structured to provide immediate growth capital to the company. Initial proceeds will be used to support Talyst’s expansion into the long-term care and correctional markets, as well as its plans to achieve greater penetration in acute-care market.

Located in Seattle, Washington, Talyst is a leader in pharmacy automation providing enterprise-wide medication management across entire health systems. Its solutions offer greater inventory control, enhanced workflow efficiency and improved patient safety. Talyst was founded in 2002 to provide easy-to-use, automated medication management systems to acute-care hospital pharmacies.

The funding of Talyst underscores ORIX Ventures’ intent to forge partnerships with fast-growing, later stage companies, as well as its particular interest in health care companies.

“We believe this funding from ORIX Ventures validates the market leadership and growth potential of Talyst,” said CEO Carla Corkern. “Having a strong partner, such as ORIX Ventures, which can support the financial needs of Talyst throughout our expansion gives us a competitive edge by enabling us to respond quickly to marketplace opportunities.”

David Orlandella, a Principal at ORIX Ventures, commented, “We are pleased to partner with Talyst’s management team which has demonstrated an impressive ability to strategically scale the company and build a leading technology company in the pharmacy automation space.”

About ORIX Ventures

ORIX Ventures provides customized financial solutions up to $50 million in capital per transaction to mid- and late-stage companies which have established customers and run-rate revenues of $10 million or greater. Since its inception in 2001, ORIX Ventures has invested in more than 100 growth companies throughout the U.S. and Canada. www.orixventures.com. ORIX USA is a Dallas, Texas-based financial services and investment firm with more than 1,400 employees and primary offices in Dallas, New York, Los Angeles, Columbus and Minneapolis. ORIX USA holds approximately $6 billion of assets and manages through various subsidiaries an additional $25 billion. www.orix.com. ORIX USA is a wholly owned subsidiary of ORIX Corporation, a Tokyo-based, publicly owned international financial services company with operations in 27 countries worldwide. ORIX Corporation is listed on the Tokyo (8591) and New York Stock Exchanges (IX).

Follow us on Twitter: @orixventures

About Talyst

Talyst is a leader in pharmacy automation and engineers the safer pharmacy. The company’s solutions provide enterprise-wide medication management across entire health systems to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2012, Talyst has installed automated systems in more than 600 integrated healthcare systems, acute-care hospitals, long-term care facilities, and correctional institutions. Talyst offers a powerful software platform with a suite of hardware components to meet specific needs of health care providers. Visit Talyst at www.talyst.com.

Contacts:

C. Pharr & Company for ORIX Ventures
Shelby Sabin Menczer, 214-763-6068
Shelby@pharrpr.com
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here